Pediatric emergencies in children with psychiatric conditions

Pediatric Emergency Care

Volumn 14, Issue 1, 1998, Pages 42-50

  Sater, Nicola ^a   Constantino, John N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Child psychiatric disorders; Pediatric emergencies; Psychiatric emergencies; Psychopharmacology

Indexed keywords

BUTYROPHENONE; CARBAMAZEPINE; CLOZAPINE; DEXAMPHETAMINE; LITHIUM; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; PEMOLINE; PHENOTHIAZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AKATHISIA; BLOOD DYSCRASIA; CHILD ABUSE; CHILD PSYCHIATRY; DELIRIUM; DYSTONIA; EATING DISORDER; EXTRAPYRAMIDAL SYMPTOM; FACTITIOUS DISEASE; GASTROINTESTINAL SYMPTOM; HOMICIDE; HUMAN; MALINGERING; MENTAL DISEASE; MUNCHAUSEN SYNDROME; NEUROLEPTIC MALIGNANT SYNDROME; NEUROSIS; PARKINSONISM; PSYCHOSIS; REVIEW; SLEEP DISORDER; SUICIDAL BEHAVIOR; TARDIVE DYSKINESIA;

EID: 0031931645     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006565-199802000-00012     Document Type: Review

References (57)

1. Murphy GE. The physician's responsibility for suicide. II. Errors of omission. Ann Intern Med 1975;82:305-309.
2. Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: Clinical aspects. Br J Psychiatry 1974;125:355-373.
3. Schaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996;53:339-348.
4. Brent DA, Perper JA, Goldstein CE, et al. Risk factors for adolescent suicide. Arch Gen Psychiatry 1988;45:581-588.
5. Kellerman AL, Rivara FP, Somes G, et al. Suicide in the home in relation to gun ownership. N Engl J Med 1992;327:467-472.
6. Henriksson MM, Aro HM, Marttunen MJ, et al. Mental disorders and comorbidity in suicide. Am J Psychiatry 1993;150:935-940.
7. Winokur G, Black DW. Suicide - what can be done? [letter]. N Engl J Med 1992; 327:490-491.
8. Brent DA, Perper JA, Allman CJ. Alcohol, firearms, and suicide among youth. JAMA 1987;257:3369-3372.
9. Murphy BM, Puffet A. Pathways to suicide prevention. Br J Hosp Med 1995;54:11-14.
10. Satcher D. Violence as a public health issue. Bull NY Acad Med 1995;72:46-56.
11. Kellerman AL, Rivara FP, Rushforth NB, et al. Gun ownership as a risk factor for homicide in the home. N Engl J Med 1993;329:1084-1091.
12. Russell AT. The clinical presentation of childhood-onset schizophrenia. Schizophr Bull 1994;20:631-646.
13. Wakeling A. Epidemiology of anorexia nervosa. Psychiatry Res 1996;62: 3-9.
14. Bryant-Waugh R Lask B. Eating disorders in children. J Child Psychol Psychiatry 1995:36:191-202.
15. '5. Sharp CW, and Freeman CPL. The medical complications of anorexia nervosa Br J Psychiatry 1993;62:452-462.
16. Berkowitz CD. Pediatric abuse: New patterns of injury. Emerg Med Clin North Am 1995;13:321-341.
17. Pimentel L, Trommer, L. Cyclic antidepressant overdose. Emerg Med Clin North Am 1994;12:533-547.
18. Pentel PR, Keyler DE. Drug specific antibodies as antidotes for tricyclic antidepressant overdose. Toxicol Let 1995;82-83:801-806.
19. Power BM, Pinder M, Hackett LP, et al. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care 1995;23:499-502.
20. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-320.
21. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148: 705-713.
22. Zornberg GL, Hegarty JD. Adverse interaction between propoxyphene and phenelzine [letter]. Am J Psychiatry 1993;150:1270-1271.
23. Hollister LE and Csernansky JG. Antipsychotic medications. In: Clinical pharmacology of psychotherapeutic drugs, 3rd Ed. New York: Churchill Livingstone, 1990;97-125.
24. Silverstein FS, Johnston MV. Risks of neuroleptic drugs in children. J Child Neurol 1987;2:41-3.
25. Keepers GA, Casey DE. Prediction of neuroleptic-induced dystonia. J Clin Psychopharmacol 1987;7:342-345.
26. Murray V.Laryngeal dystonia [letter]. Br J Psychiatry 1995;167:168-169.
27. Thorburn R. Dystonia and neuroleptic medication [letter]. Br J Psychiatry 1995;167:114.
28. Ebadi M, Srinvasan SK. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders. Pharmacol Rev 1995;47: 575-604.
29. Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol 1995;9(suppl):21-27.
30. Mazurek MF, Rosebush PI. Circadian pattern of acute, neuroleptic-induced dystonia. Am J Psychiatry 1996;153:708-710.
31. Bruun RD. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 1988;145: 621-624.
32. Leiberman JA, Saltz BL, Johns CA, et al. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503-510.
33. Campbell M, Grega MD, Green WH, et al. Neuroleptic-induced dyskinesias in children. Clin Neuropharmacol 1983;6:207-222.
34. Gualtieri CT, Quade D, Hicks RE, et al. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Am J Psychiatry 1984;141:20-23.
35. Velamoor VR, Norman RMG, Caroff SN, et al. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994;182:168-173.
36. Burke C, Fulda GL, Castellano J. Neuroleptic malignant syndrome in a trauma patient. J Trauma 1995;39:796-798.
37. Clark WG, Lipton JM. Drug-related heatstroke. Pharmacol Ther 1984;26: 345-388.
38. Tacke U, Venalainen E. Heat stress and neuroleptic drugs. J Neurol Neurosurg Psychiatry 1987;50:937-938.
39. Lazarus A. Differentiating neuroleptic-related heatstroke from neuroleptic malignant syndrome. Psychosomatics 1989;30:454-456.
40. Baldwin DS, Montgomery SA. First clinical experience with olanzapine (LY 170053): Results of an open-label safety and dose-ranging study in patients with schizophrenia. Int Clin Psychopharmacol 1995;10: 239-244.
41. Gitlin MJ. Lithium-induced renal insufficiency. J Clin Psychopharmacol 1993;13:276-279.
42. Waller DG, Edwards JG. Lithium and the kidney: An update. Psychol Med 1989;19:825-831.
43. Schou M. Effects of long-term lithium treatment on kidney function: An overview. Psychiatry Res 1988;22:287-296.
44. Berkovitch M, Pope E, Phillips J, et al. Pemoline-associated fulminant liver failure: Testing the evidence for causation. Clin Pharmacol Ther 1995;57:696-698.
45. Smith MJ, Breitbart WS, Platt MM. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1994;10:35-77.
46. Prugh DG, Wagonfeld S, Metcalf D, et al. A clinical study of delirium in children and adolescents. Psychosom Med 1980;42(suppl):177-195.
47. Boutros NN. A review of indications for routine EEG in clinical psychiatry. Hosp Community Psychiatry 1992;43:716-719.
48. Lipowski ZJ. Update on delirium. Psychiatr Clin North Am 1992;15: 335-346.
49. Lell ME. The psychiatrist in the emergency room: Neurologic emergencies. In: Kaufman DM, Solomon GE, Pfeffer CR, eds. Child and adolescent neurology for psychiatrists. Baltimore: Williams & Wilkins, 1992; 228-237.
50. American Psychiatric Association. Diagnositc and statistical manual of mental disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
51. Campo JV, Fritsch SL. Somatization in children and adolescents. J Am Acad Child Adolesc Psychiatry 1994;33:1223-1235.
52. Schecker N. Childhood conversion reactions in the emergency department. Part II. General and specific features. Pediatr Emerg Care 1990;6:46-51.
53. Folks DG. Munchausen's syndrome and other factitious disorders. Neurol Clin 1995;13:267-281.
54. Taylor S, Hyler SE. Update of factitious disorders. Int J Psychiatry Med 1993;23:81-94.
55. Faust D, Hart K. Pediatric malingering: The capacity of children to fake believable deficits on neuropsychological testing. J Consult Clin Psychol 1988;56:578-582.
56. Rosenberg DA. Web of deceit: A literature review of Munchausen syndrome by proxy. Child Abuse Negl 1987;11:547-563.
57. Schreier HA, Libow JA. Munchausen by proxy syndrome: A modern pediatric challenge. J Pediatr 1994;125:S110-S115.